Pharmacists’ Patient Care Process: State “Scope of Practice” Priorities for Action

Abstract

To fully engage in the Pharmacists’ Patient Care Process, pharmacists must be able to (1) participate in a Collaborative Practice Agreement, (2) order and interpret laboratory tests, (3) prescribe certain medications, (4) adapt medications, (5) administer medications, and (6) effectively delegate tasks to support staff. Each of these activities is dependent on state scope of practice laws, but these laws are not binary. Various state-level restrictions allow us to view these activities on a continuum from more restrictive to less restrictive. This continuum will allow pharmacy and public health stakeholders to identify priorities for action in their states.

Pharmacy technician-administered immunizations: A five-year review

“…8 In 2017, some states still limited pharmacists to administering certain immunizations or limited the patient populations pharmacists could administer immunizations to (e.g., patient age limits). 28 At issue was whether special interest groups such as medical associations would increase their resistance to pharmacybased immunizations as a result of technicians also taking on this task.…”

Pharmacy Regulatory Innovation Index: Benchmarking the regulatory environment in 10 western states

“…Tsuyuki 10 has called for pharmacists to have a "full scope" of practice as a standard of carednot just as a "nice to have" luxurydinclusive of administering injections, prescribing, ordering laboratory tests, and disease management. Adams and Weaver 11,12 identified 6 legal requirements for pharmacists to fully engage in the Pharmacists' Patient Care Process (PPCP); in addition to the "full scope" requirements mentioned by Tsuyuki, 10 the authors stated that pharmacists need to also have the authority to enter into a collaborative practice agreement (CPA) and delegate tasks to support personnel.…”

Establishment of a Framework to Support Multi-Faceted Initiatives for Pharmacy-Practice Transformation: Lessons Learned

“…However, despite the evident impact and success, the number of pharmacists providing these services in the private sector is relatively small, largely due to legislative, regulatory, and resource barriers. These barriers are complex and have led to unfair and inequitable reimbursement models that impede practice sustainability [ 6 , 7 , 8 , 9 , 10 ].…”